Top

Published in:

01-04-2009 | Review Article

Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients

Authors: Iacopo Cancelli, Massimiliano Beltrame, Gian Luigi Gigli, Mariarosaria Valente

Published in: Neurological Sciences | Issue 2/2009

Abstract

Drug consumption in older people is usually high and many prescribed medications have unsuspected anticholinergic (ACH) (Table 1) properties. Drug induced ACH side-effects are particularly severe in aging brain and even more in demented patients. This review will focus on the association between ACH drug intake and the risk of developing central nervous system side-effects in elderly people. The threat of developing cognitive impairment, psychosis and delirium will be particularly analyzed.

Fick DM, Cooper JW, Wade WE et al (2003) Updating the Beers criteria for potentially inappropriate use in older adults. Arch Intern Med 163:2716–2724PubMedCrossRef

Salom IL, Davis K (1995) Prescribing for older patients: how to avoid toxic drug reactions. Geriatrics 50:37–40PubMed

Royal College of Physicians (1997) Medication for elderly people. RCP, London

Furniss L, Burns A, Craig SK et al (2000) Effects of a pharmacist’s medication in nursing and residential homes. Br J Psychiatry 176:563–567PubMedCrossRef

Tollefson GD, Montagne-Clouse J, Lancaster SP (1999) The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population. J Neuropsychiatry Clin Neurosci 3:314–319

Tune L, Carr S, Hoag E et al (1992) Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry 149:1393–1394PubMed

Blazer DG, Federspiel CF, Ray WA et al (1983) The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. J Gerontol 38:31–35PubMed

Lechevallier-Michel N, Molimard M, Dartigues JF et al (2005) Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol 59:143–151PubMedCrossRef

Landi F, Russo A, Liperoti R et al (2007) Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther 81:235–241PubMedCrossRef

10.

Roe CM, Anderson MJ, Pharm D et al (2002) Use of anticholinergic medications by older adults with dementia. JAGS 50:836–842CrossRef

11.

Sunderland T, Tariot PN, Cohen RM et al (1987) Anticholinergic sensivity in patients with dementia of Alzheimer’s type and age-matched controls. Arch Gen Psychiatry 44:418–426PubMed

12.

Mintzer J, Burns A (2000) Anticholinergic side-effects of drugs in elderly people. J R Soc Med 93:457–462PubMed

13.

Feinberg M (1993) The problems of anticholinergic adverse effects in older patients. Drugs Aging 3:335–348PubMedCrossRef

14.

Tune LE (2001) Anticholinergic effects of medication in elderly people. J Clin Psychiatry 62(suppl 21):11–14PubMed

15.

Cao YJ, Mager DE, Simonsick EM et al. (2008) Physical and cognitive performance and burden of anticholinergics, sedatives and ACE inhibitors in older women. Clin Pharmacol Ther 83:422–429

16.

Cancelli I, Gigli GL, Piani A et al (2008) Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people. J Clin Psychopharmacol 28(6):654–659PubMedCrossRef

17.

Ancelin ML, Artero S, Portet F et al (2006) Non degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332:455–459PubMedCrossRef

18.

Bottigi KA, Salazar JC, Yu L et al (2006) Long-term cognitive impact of anticholinergic medications in older adults. Am J Geriatr Psychiatry 14:980–984CrossRef

19.

Cancelli I, Valentinis L, Merlino G et al (2008) Drugs with anticholinergic properties as a risk factor for psychosis in patients affected by Alzheimer’s disease. Clin Pharmacol Ther 84:63–68PubMedCrossRef

20.

Cancelli I, Marcon G, Balestrieri M (2004) Factors associated with complex visual hallucinations during antidepressant treatment. Hum Psychopharmacol 19:577–584PubMedCrossRef

21.

Trzepacz PT (1996) Anticholinergic model for delirium. Semin Clin Neuropsychiatry 1:294–303PubMed

22.

Flacker JM, Cummings V, Mach JR et al (1998) The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry 6:31–41PubMed

23.

Mach JR, Dysken MW, Kuskowski M et al (1995) Serum anticholinergic activity in hospitalized older persons with delirium: a preliminary study. J Am Geriatr Soc 43:491–495PubMed

24.

Han L, McCusker J, Cole M et al (2001) Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 161:1099–1105PubMedCrossRef

25.

Tune LE, Bylsma FW (1991) Benzodiazepine-induced and anticholinergic-induced delirium in elderly. Int Psychogeriatr 3:397–408PubMedCrossRef

26.

Bartus RT, Dean RL, Beer B et al (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–414PubMedCrossRef

27.

Moore AR, O’Keeffe ST (1999) Drug-induced cognitive impairment in the elderly. Drugs Aging 15:15–28PubMedCrossRef

28.

Flicker C, Serby M, Ferris SH (1990) Scopolamine effects on memory, language, visual-spatial praxis and psychomotor speed. Psychopharmacology 100:243–250PubMedCrossRef

29.

Ray PG, Meador KJ, Loring DW et al (1992) Central anticholinergic hypersensitivity in aging. J Geriatr Psychiatry Neurol 5:72–77PubMed

30.

Mulsant BH, Pollock BG, Kirshner M et al (2003) Serum anticholinergic activity in a community-dwelling sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 60:198–203PubMedCrossRef

31.

Folstein MF, Folstein SE, McHug PH (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef

32.

Benton A (1965) Applications Cliniques et Expèrimentales. Centre de Psychologie Appliquèe. Manuel pour l’Application du Test de Rètention Visuelle, Paris

33.

Reisberg B, Ferris SH, De Leon MJ et al (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139:1136–1139PubMed

34.

Doraiswamy PM, Husain MM (2006) Anticholinergic drugs and elderly people: a no brainer? Lancet Neurol 5:379–380PubMedCrossRef

35.

Cummings JL, Back C (1998) The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer’s disease. Am J Geriatr Psychiatry 6:S64–S78PubMedCrossRef

36.

Lai MK (2001) Psychosis of Alzheimer’s disease is associated with elevated muscarinic M2 receptor binding in the cortex. Neurology 57:805–811PubMed

37.

Wynn ZA, Cummings JL (2004) Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer’s disease. Dement Geriatr Cogn Disord 17:100–108PubMedCrossRef

38.

Adler LE, Olincy A, Waldo M et al (1998) Schizophrenia, sensory gating and nicotinic receptors. Schizophr Bull 24:189–202PubMed

39.

Lemstra AW, Eikelenboom P, Van Gool WA (2003) The cholinergic deficiency syndrome and its therapeutic implications. Gerontology 49:55–60PubMedCrossRef

40.

Cancelli I, Cadore IP, Merlino G et al (2006) Sensory gating deficit assessed by P50/Pb middle latency event related potential in Alzheimer’s disease. J Clin Neurophysiol 23:421–425PubMedCrossRef

41.

Murat G, Murat P, Unal S (2006) Psychotic disorder induced by oxybutynin: presentation of two cases. Clin Drug Invest 26:603–606CrossRef

42.

Cummings JL, Mega M, Gray K et al (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314PubMed

43.

Jeste DV, Finkel SI (2000) Psychosis of Alzheimer’s disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry 8:29–34PubMedCrossRef

44.

Fleminger S (2002) Remembering delirium. Br J Psychiatry 180:4–5PubMedCrossRef

45.

Elie M, Cole M, Primeau FJ et al (1998) Delirium risk factors in elderly hospitalized patients. J Gen Intern Med 13:204–212PubMedCrossRef

46.

Inouye SK, Charpentier PA (1996) Precipitating factors for delirium in hospitalized elderly patients: predictive model and interrelationship with baseline vulnerability. JAMA 275:852–857PubMedCrossRef

47.

Francis J, Martin D, Kapoor W (1990) A prospective study of delirium in hospitalized elderly. JAMA 263:1097–1101PubMedCrossRef

48.

Schor JD, Levkoff SE, Lapsitz LA et al (1992) Risk factors for delirium in hospitalized elderly. JAMA 267:827–831PubMedCrossRef

49.

Lipowski ZJ (1990) Delirium: acute confusion state. Oxford University Press Inc, New York

50.

Lindesay J, Macdonald A, Starke I (1990) Delirium in the elderly. Oxford University Press, Oxford

51.

Ross CA (1991) CNS arousal system: possible role in delirium. Int Psychogeriatr 3:353–371PubMedCrossRef

52.

Gibson GE, Blass JP, Hm Huang et al (1991) The cellular basis of delirium and its relevance to age-related disorder including Alzheimer’s disease. Int Psychogeriatr 3:373–395PubMedCrossRef

53.

Tune LE, Egeli S (1999) Acetylcholine and delirium. Dement Geriatr Cogn Disord 10:342–344PubMedCrossRef

54.

Dening TR, Berrios GE (1990) Wilson’s disease: a longitudinal study of psychiatric symptoms. Biol Psychiatry 28:255–265PubMedCrossRef

55.

Gilley DW, Wilson RS, Bennett DA et al (1991) Cessation of driving and unsafe motor vehicle operation by dementia patients. Arch Intern Med 151:941–946PubMedCrossRef

56.

WHO Collaborating centre for drug statistics methodology. Anatomical therapeutics chemical classification system. Available at http://www.whocc.no/atcddd/

57.

Ness J, Hoth A, Barnett MJ et al (2006) Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptoms burden, and drug events. Am J Geriatr Pharmacother 4:42–51PubMedCrossRef

58.

Rudd KM, Raehl C, Bond CA et al (2005) Methods for assessing drug-related anticholinergic activity. Pharmacotherapy 25:1592–1601PubMedCrossRef

59.

Carnahan RM, Lund BC, Perry PJ et al (2004) The concurrent use of anticholinergics and cholinesterase inhibitors: rare events or common practice? JAGS 52:2082–2087CrossRef

Title: Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients
Authors: Iacopo Cancelli
Massimiliano Beltrame
Gian Luigi Gigli
Mariarosaria Valente
Publication date: 01-04-2009
Publisher: Springer Milan
Published in: Neurological Sciences / Issue 2/2009
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-009-0033-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2009

Cyclic hyperammoniemic encephalopathy and epileptiform triphasic waves: problems in differential diagnosis with nonconvulsive status epilepticus, reply

Familial cerebral cavernous malformation: report of a further Italian family

Painful neuropathy in subclinical hypothyroidism: clinical and neuropathological recovery after hormone replacement therapy

Safety of carotid stenting for stroke prevention: need of an independent outcome assessor

Inverse relationship between multiple sclerosis and allergic respiratory diseases

Radio-induced low-grade glioma: report of two cases and review of the literature